Advanced Life Sciences Holdings, Inc. (ADLS) Wrap Up:

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs in the areas of infectious disease, oncology, and inflammation. The company has a worldwide license from Abbott Laboratories to develop and commercialize its lead candidate, cethromycin, an antibiotic that is in Phase III clinical development for the treatment of respiratory tract infections. It is also developing ALS-357, a compound for the treatment of malignant melanoma; and ALS-886, a therapeutic that is in preclinical development for the treatment of inflammation-related tissue damage, including tissue damage associated with acute respiratory distress...